文献速递泌尿生殖腹部MRPETCT

评估前列腺癌的腺外侵犯:MRI与PSMA-PET/CT的实用性整合

Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT.
PubMed 文献 · Abdom Radiol (NY) · 2025-04-19

本研究纳入2021-2024年接受多参数MRI和PSMA-PET/CT后行根治性前列腺切除术的67例新诊断前列腺癌患者,探索三种整合MRI与PSMA-PET/CT评估腺外侵犯的实用性方法。基于MRI的包膜接触长度(LCC)以≥1.7 cm为阈值获得最高AUC 0.82;将MRI形态学信息与PSMA-PET/CT功能信息(SUVmax>12时对LCC低于阈值病灶升级怀疑)整合后敏感度80.4%、特异度81.2%,敏感度显著高于单独MRI-LCC(66.7%,p=0.02),特异度无显著差异(87.5%,p>0.99)。作者认为该整合方法可能是一种简单实用的整合方法。

要点

  • MRI-LCC以≥1.7 cm为阈值评估EPE的AUC最高,为0.82(0.71-0.92)。
  • MRI形态学联合PSMA-PET/CT功能信息(SUVmax>12升级LCC<1.7 cm病灶)敏感度80.4%、特异度81.2%。
  • 该整合方法较单独MRI-LCC敏感度显著提高(80.4% vs 66.7%,p=0.02),特异度无显著差异(81.2% vs 87.5%,p>0.99)。

核心结论

  • 将MRI形态学信息与PSMA-PET/CT功能信息整合,对前列腺癌腺外侵犯评估表现出良好诊断性能,可能是一种简单实用的整合方法。

研究设计与样本

  • 连续性纳入2021-2024年新诊断前列腺癌、接受多参数MRI和PSMA-PET/CT后行根治性前列腺切除术的患者67例(中位年龄66岁),以根治性前列腺切除病理为参考标准。

诊断标准与关键数值

  • MRI-LCC以≥1.7 cm为阈值评估EPE的AUC为0.82(0.71-0.92);整合Likert量表(MRI EPE分级/PSMA Likert量表任一或两者阳性为阳性)敏感度80.4%(41/51)、特异度31.3%(5/16);P评分(PI-RADS联合PRIMARY)敏感度31.3%(16/51)、特异度87.5%(14/16);MRI形态学联合PSMA-PET/CT功能信息(SUVmax>12时升级LCC<1.7 cm病灶的怀疑)敏感度80.4%(41/51)、特异度81.2%(13/16)。

临床应用与阅片要点

  • 作者认为,结合MRI形态学信息与PSMA-PET/CT上PSMA表达可能是一种简单实用的整合方法;该整合方法在SUVmax>12时对LCC<1.7 cm的8例患者升级怀疑,其中87.5%(7/8)为纠正性升级并具有病理学EPE。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore pragmatic approaches integrating MRI and PSMA-PET/CT for evaluating extraprostatic extension (EPE) of prostate cancer (PCa).

METHODS: Consecutive patients with newly-diagnosed PCa that underwent multiparametric MRI and PSMA-PET/CT, followed by radical prostatectomy in 2021-2024 were included. Imaging parameters assessed on both modalities were: size, length of capsular contact (LCC), Likert scales (MRI EPE grade/PSMA Likert scale), PI-RADS/PRIMARY scores, and SUVmax. Three pragmatic integrated approaches were tested: (1) Integration of Likert scales (positive if either or both MRI and PSMA-PET/CT were positive); (2) P score (framework combining PI-RADS + PRIMARY); and (3) combining MRI morphological information with PSMA-PET/CT functional information (upgrading suspicion of lesions with LCC below cutoff if SUVmax>12). Diagnostic performance was tested with receiver operating characteristic (ROC) curves and compared using DeLong and McNemar tests.

RESULTS: 67 men (median age, 66 years) with EPE in 76.1% (51/67) were included. Area under ROC curves (AUC) were 0.61-0.82; MRI-based LCC yielded the highest AUC 0.82 (0.71-0.92) with cutoff of ≥ 1.7 cm. Integrated Likert scale (MRI EPE grade/PSMA Likert scale) showed sensitivity of 80.4% (41/51) and specificity of 31.3% (5/16). P score (PI-RADS/PRIMARY) demonstrated sensitivity of 31.3% (16/51) and specificity of 87.5% (14/16). Combining morphological MRI information with functional PSMA-PET/CT yielded sensitivity and specificity of 80.4% (41/51) and 81.2% (13/16), respectively, which demonstrated significantly higher sensitivity but non-significantly different specificity compared with MRI-based LCC alone (66.7% [34/51, p = 0.02] and 87.5% [14/16, p > 0.99]). This approach upgraded suspicion in 8 patients with LCC < 1.7 cm due to SUVmax>12 among which 87.5% (7/8) were corrected upgraded and had pathological EPE.

CONCLUSION: Several pragmatic approaches were explored for integrating MRI and PSMA-PET/CT to assess EPE in PCa. Combining morphological information from MRI and PSMA expression on PET/CT demonstrated good diagnostic performance and may be a simple pragmatic integrated method that can be used.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Woo S, Freedman D, Becker AS, et al. Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT. Abdom Radiol (NY). 2025. PMID: 40252100. doi:10.1007/s00261-025-04948-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。